Evidence map›Paper›PMID 34455749›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2021

[The expression and prognostic value of PD-1, TIM-3, LAG-3 and BTLA in extranodal NK/T cell lymphoma].

L Nie, X Y Liu, R J Ma, X L Yuan, L Jiang, J Yang, A X Hu, Z Li, Z M Zhu

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

L NieDepartment of Hematology, Henan Provincial Hospital, Zhengzhou 450003, China Liu Xiaoyin is now working at the First People's Hospital of Pingdingshan, Pingdingshan 467099, China.
X Y LiuDepartment of Hematology, Henan Provincial Hospital, Zhengzhou 450003, China.
R J MaDepartment of Hematology, Henan Provincial Hospital, Zhengzhou 450003, China.
X L YuanDepartment of Hematology, Henan Provincial Hospital, Zhengzhou 450003, China.
L JiangDepartment of Hematology, Henan Provincial Hospital, Zhengzhou 450003, China.
J YangDepartment of Hematology, Henan Provincial Hospital, Zhengzhou 450003, China.
A X HuDepartment of Pathology, Henan Provincial Hospital, Zhengzhou 450003, China.
Z LiDepartment of Pathology, Henan Provincial Hospital, Zhengzhou 450003, China.
Z M ZhuDepartment of Hematology, Henan Provincial Hospital, Zhengzhou 450003, China Institute of Hematology, Henan Provincial Hospital, Zhengzhou 450003, China Nie Lu is now working at Gansu Provincial Hospital, Lanzhou 730000, China.
Henan Provincial People's Hospital · CNPingdingshan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lymphoma, Extranodal NK-T-CellAntigens, CDHepatitis A Virus Cellular Receptor 2HumansLymphocyte Activation Gene 3 ProteinPrognosisProgrammed Cell Death 1 ReceptorReceptors, ImmunologicAntigens, CDBTLA protein, humanHAVCR2 protein, humanHepatitis A Virus Cellular Receptor 2Lag3 protein, humanLymphocyte Activation Gene 3 ProteinPDCD1 protein, humanProgrammed Cell Death 1 ReceptorReceptors, Immunologic

Identifiers

PMID34455749
PMCPMC8408487
OpenAlexW3196819264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.